| DexAmaz vs Kazuya | 69–52 | 57.02% |
| DexAmaz vs Heihachi | 56–56 | 50.00% |
| DexAmaz vs Jin | 53–47 | 53.00% |
| DexAmaz vs King | 50–44 | 53.19% |
| DexAmaz vs Hwoarang | 37–32 | 53.62% |
| DexAmaz vs Reina | 41–27 | 60.29% |
| DexAmaz vs Bryan | 38–29 | 56.72% |
| DexAmaz vs Steve | 31–27 | 53.45% |
| DexAmaz vs Lili | 24–26 | 48.00% |
| DexAmaz vs Law | 25–22 | 53.19% |
| DexAmaz vs Lee | 21–24 | 46.67% |
| DexAmaz vs Clive | 20–24 | 45.45% |
| DexAmaz vs Yoshimitsu | 29–14 | 67.44% |
| DexAmaz vs Dragunov | 24–18 | 57.14% |
| DexAmaz vs Devil Jin | 14–25 | 35.90% |
| DexAmaz vs Paul | 19–19 | 50.00% |
| DexAmaz vs Nina | 21–17 | 55.26% |
| DexAmaz vs Azucena | 21–17 | 55.26% |
| DexAmaz vs Lidia | 21–16 | 56.76% |
| DexAmaz vs Jun | 21–14 | 60.00% |
| DexAmaz vs Asuka | 13–18 | 41.94% |
| DexAmaz vs Alisa | 24–7 | 77.42% |
| DexAmaz vs Feng | 11–16 | 40.74% |
| DexAmaz vs Victor | 12–15 | 44.44% |
| DexAmaz vs Eddy | 13–9 | 59.09% |
| DexAmaz vs Lars | 8–12 | 40.00% |
| DexAmaz vs Leo | 10–9 | 52.63% |
| DexAmaz vs Xiaoyu | 7–11 | 38.89% |
| DexAmaz vs Zafina | 7–8 | 46.67% |
| DexAmaz vs Leroy | 10–3 | 76.92% |
| DexAmaz vs Jack-8 | 5–6 | 45.45% |
| DexAmaz vs Kuma | 5–6 | 45.45% |
| DexAmaz vs Raven | 8–3 | 72.73% |
| DexAmaz vs Claudio | 5–3 | 62.50% |
| DexAmaz vs Shaheen | 6–1 | 85.71% |
| DexAmaz vs Panda | 3–1 | 75.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.